[1]
Karakiewicz, P.I., Zaffuto, E., Kapoor, A., Basappa, N.S., Bjarnason, G.A., Blais, N., Breau, R.H., Canil, C., Drachenberg, D., Hotte, S.J., Jeldres, C., Jewett, M.A., Kassouf, W., Kollmannsberger, C., Lavallée, L.T., Maloni, R., Patenaude, F., Pouliot, F., Reaume, M.N., Sabbagh, R., Shayegan, B., So, A., Soulières, D., Tanguay, S., Wood, L. and Bandini, M. 2018. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Canadian Urological Association Journal. 12, 6 (Mar. 2018), 173–80. DOI:https://doi.org/10.5489/cuaj.5187.